Hôpital de la Source

Orléans 45067

0 studies enrolling now · 3 studies all time

What they study most

Gastrointestinal Stromal Tumors, Pancreatic Cancer, Severe Sepsis

Studies at this site

• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) — Stopped early
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused